Correspondence and communication| Volume 65, ISSUE 10, P1430-1431, October 2012

Prescribing for athletes and plastic surgery

      Over 14,000 athletes will visit the United Kingdom for the 2012 Olympic and Paralympic Games this summer.

      London Olympics; 2012:; [accessed 02.05.12].

      The use of performance enhancing substances has a history almost as long as competitive sport itself and cheating in this manner remains an unfortunate minority activity in today's competitions. The first list of prohibited substances was published by the International Olympic Committee in 1967. The World Anti-Doping Agency (WADA) was founded in 1999 to harmonize anti-doping policies across all sports and countries. It publishes the world anti-doping code and details prohibited substances in the WADA prohibited list.

      World Anti-Doping Agency:; [accessed 02.05.12].

      The list was revised on the 1st January 2012.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. London Olympics; 2012:; [accessed 02.05.12].

      2. World Anti-Doping Agency:; [accessed 02.05.12].

        • Mace A.
        • Smith R.
        • Sandhu G.
        How we do it: ENT prescribing to competitive athletes – a review of current regulations.
        Clin Otolaryngol. 2005; 30: 201-205
        • Smith R.
        • Barnsley L.
        • Kannangara S.
        • Mace A.
        Rheumatological prescribing in athletes: a review of the new world anti-doping agency guidelines.
        Rheumatology (Oxford). 2004; 43: 1473-1475
      3. Avois L, Bailloux I, Desmarcheliers A, et al. Synthetic glucocorticosteroids administration: urinary excretion study of triamcinolone acetonide. In: 25nd Cologne Workshop on Dope Analysis; Feb 26–March 2, 2007. Cologne.